For Participants
Your Role in
Clinical Research
By participating in clinical trials, you help advance medicine while gaining access to innovative treatments and expert medical support.
What is Clinical Research?
Clinical research studies health and illness in both healthy individuals and those with medical conditions to evaluate the safety and effectiveness of treatments, devices, and diagnostics. This is done through clinical trials.
Clinical trials are carefully designed studies that test new treatments or approaches to determine if they are safe and beneficial for people. They help researchers learn what works, what doesn’t, and improve care for different conditions.
Why Participate in a Clinical Trial?
Clinical trials are essential for finding new ways to prevent, detect, and treat disease. They drive medical advancements and offer hope for better treatments in the future.
People participate for many reasons—some to help advance science, others to access new treatment options not otherwise available. Participants also receive care and monitoring from a dedicated medical research team throughout the study.
We Appreciate Your Interest in Clinical Research
Only by clinical trials and research is it possible to find newer, more innovative therapies. We believe that it is vital to contribute to the understanding and development of these therapies through testing and investigational work. If you’d like to help move medicine forward, please fill out your information here.
Our recruitment team will contact you when there is a clinical trial for healthy volunteers or for participants that matches your interest. You can always call our office during business hours to apply over the phone.
Study Opportunities
Enrolling & Upcoming
Study Opportunities
Type 2 Diabetes with Ozempic
Health Volunteers - Vaccines
Diagnostic for Obstructive Sleep Apnea
Diabetes with Risk of Heart Failure
Overweight & Obesity GLP-1 Study
Obesity Associated with Type 2 Diabetes
At Home Colon Cancer Screening
Now Enrolling
Type 2 Diabetes with Ozempic
This study is enrolling adults ages 18 to 70 who have type 2 diabetes and are currently taking Ozempic while being treated with zero to two antihyperglycemic medications. Participants must meet specific blood sugar and body mass index criteria to be eligible.
Qualified participants may receive study‑related care and compensation of up to $2,638 for time and participation. Participation may help advance future treatments for type 2 diabetes.
Coming Soon
Healthy Volunteers - Vaccines
An upcoming study that will be enrolling adults ages 65 years of age and older who have not yet received a Flu shot. Qualified participants may be reimbursed for their time and travel.
Now Enrolling
Diagnostic for Obstructive Sleep Apnea
This study is enrolling healthy adults ages 22 and older to help evaluate whether wearable devices, such as a Fitbit or smartwatch, can detect signs of sleep apnea in a simpler way. No medications or treatments are involved.
Qualified participants will complete two overnight stays at a sleep center. Compensation of up to $550 may be provided for participants’ time and effort. Your participation may help improve future sleep screening tools.
Now Enrolling
Diabetes with Risk of Heart Failure
This study is enrolling adults with type 2 diabetes who are currently taking diabetes medication and have established cardiovascular disease, such as a history of heart attack, stroke, or peripheral artery disease. Participants must also have high blood pressure and meet specific eligibility criteria.
Qualified participants may receive study‑related care and compensation per visit. No fasting is required, and visits last approximately three hours. Participation may help advance future treatments for diabetes and cardiovascular disease. Pre‑approval is required.
Now Enrolling
Overweight & Obesity GLP-1 Study
This study is enrolling adults ages 18 to 65 who are overweight or obese and experiencing gastrointestinal symptoms. Participants must meet specific body mass index criteria and be willing to start an FDA‑approved GLP‑1 injection, such as Wegovy or Zepbound, for weight loss. Individuals with diabetes or certain gastrointestinal conditions, including IBS or IBD, are not eligible.
Qualified participants may receive study‑related care, GLP‑1 medication, rescue medications if needed, and compensation of up to $2,680 for time and participation. Pre‑approval is required. Participation may help advance future treatments for obesity and GI‑related symptoms.
Now Enrolling
Obesity Associated with Type 2 Diabetes
This study is enrolling adults ages 18 to 70 who have type 2 diabetes and are currently managing their condition with one to three diabetes medications. Participants must meet specific blood sugar and body mass index criteria.
Qualified participants may receive study‑related care and compensation of up to $2,638 for time and participation. Pre‑approval is required. Participation may help advance future diabetes treatments.
Now Enrolling
At Home Colon Cancer Screening
This study is open to those who are 40 years of age or older, have not had a colonoscopy in the past 9 years and do not have a personal history of colon cancer or other gastrointestinal conditions.
Qualified participants will be mailed an at-home blood draw kit and will need to attend a screening colonoscopy. Compensation of up to $475 may be provided for participants time and effort.
